Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Dialysis

Bioengineered vessels for dialysis access: soon to be a reality?

Nature Reviews Nephrology volume 12, pages 516–517 (2016)Cite this article

Subjects

Haemodialysis vascular access is a 'lifeline' for almost 2 million patients worldwide; yet given the substantial problems associated with access dysfunction, vascular access is also the Achilles heel of haemodialysis. Recent data suggest that use of novel bioengineered human acellular vessels for haemodialysis access might help to overcome these problems.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Bioengineered human acellular vessels: an innovation in haemodialysis access.

References

  1. Roy-Chaudhury, P., Sukhatme, V. P. & Cheung, A. K. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J. Am. Soc. Nephrol. 17, 1112–1127 (2006).

    Article  PubMed  Google Scholar 

  2. Lawson, J. H. et al. Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. Lancet 387, 2026–2034 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Dixon, B. S. et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N. Engl. J. Med. 360, 2191–2201 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lok, C. E. et al. Cumulative patency of contemporary fistulas versus grafts Clin. J. Am. Soc. Nephrol. 8, 810–818 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Porter, M. E. What is value in health care? N. Engl. J. Med. 363, 2477–2481 (2010).

    Article  CAS  PubMed  Google Scholar 

  6. Pisoni, R. L., Zepel, L., Port, F. K., Robinson, B. M. Trends in US vascular access use, patient preferences & related practices: an update from the US DOPPS practice monitor with international comparisons. Am. J. Kidney Dis. 65, 905–915 (2015).

    Article  PubMed  Google Scholar 

  7. US National Library of Medicine. ClinicalTrials.gov [online], (2016).

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, University of Arizona Health Sciences, 1501 North Campbell Avenue, Tucson, 85724, Arizona, USA

    Prabir Roy-Chaudhury

Authors
  1. Prabir Roy-Chaudhury
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prabir Roy-Chaudhury.

Ethics declarations

Competing interests

P.R.-C. is a member of the Health Economics Advisory Board for Humacyte and an investigator for the phase III HUMANITY study, which will test bioengineered human acellular vessels for haemodialysis access in patients with end-stage renal disease. He is also a consultant for Medtronic, W.L. Gore, Bard Peripheral Vascular and Cook Medical.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Roy-Chaudhury, P. Bioengineered vessels for dialysis access: soon to be a reality?. Nat Rev Nephrol 12, 516–517 (2016). https://doi.org/10.1038/nrneph.2016.119

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2016.119

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research